Today: 20 May 2026
HubSpot stock price rises in New York trade as Stifel trims target — what’s next for HUBS
23 January 2026
1 min read

HubSpot stock price rises in New York trade as Stifel trims target — what’s next for HUBS

New York, January 23, 2026, 11:09 EST — The regular session is underway.

HubSpot Inc shares climbed 1.5% to $324.31 in late morning trading Friday, after hitting a session peak of $330.69. The marketing and sales software firm’s stock was last seen roughly $4.81 higher than Thursday’s close.

The advance came as U.S. stocks mostly weakened, with Intel falling after issuing a gloomy forecast and investors shifting focus to the Federal Reserve’s meeting next week. “Guidance now is more critical than ever,” noted Peter Cardillo, chief market economist at Spartan Capital Securities. Reuters

HubSpot’s stock has seen wild swings this year, dropping roughly 56% over the last 52 weeks, according to Barchart data. The stock has traded between about $300 and $881 during that time, highlighting just how sharply investors have repriced high-growth software firms amid changing rate outlooks.

Stifel analyst J. Parker Lane stuck with a Buy rating on Friday but trimmed the price target to $500 from $550, according to broker activity reported on Yahoo Finance.

Stifel’s downgrade came amid a wider pullback in software stock valuations. The firm cited “multiple compression” as a key factor, while also noting better partner sentiment and initial momentum for HubSpot’s Breeze agents, Investing.com reported. Investing.com

A new insider filing has come in. Co-founder and director Brian Halligan offloaded 8,500 shares on Jan. 20 at $303.38 apiece, following a Rule 10b5-1 plan. After the sale, he still holds 487,344 shares. The 10b5-1 plan lets insiders set up scheduled stock sales in advance.

The key issue now: is Friday’s gain a genuine rebound or merely a bounce off a battered chart? HubSpot’s customers are mostly small businesses, and their budgets can shrink quickly when the economy weakens.

Rate risk is another factor. Should the Fed indicate no rush to cut rates, or if long-term yields rise, investors might shift away from pricey software stocks and favor more reliable cash generators instead.

Competition remains a subtle but persistent challenge. HubSpot operates in markets largely ruled by Salesforce and Adobe’s bigger suites, and investors quickly react to any sign that new products aren’t driving lasting upgrades or growth in customers.

The Fed’s meeting on Jan. 27–28 is shaping up as the next major market catalyst. HubSpot shareholders, meanwhile, are eager for the company to confirm when it will release its next earnings and provide guidance on its outlook.

Stock Market Today

  • Okta (OKTA) Stock Declines Amid Market Despite Strong Earnings Outlook
    May 19, 2026, 7:32 PM EDT. Okta (OKTA) shares fell 1.68% to $74.45, underperforming the S&P 500's slight 0.02% decline. The cloud identity management firm is expected to report earnings per share (EPS) of $0.57, a 29.55% increase year-over-year, and revenue of $649.35 million, up 11.19%. Annual forecasts predict EPS of $2.61 and revenue of $2.56 billion, marking increases of 63.13% and 13.19%, respectively. Despite the recent stock drop, Okta holds a Zacks Rank #1 (Strong Buy), reflecting optimistic analyst revisions. The stock trades at a forward price-to-earnings ratio of 29.07, above the industry average of 17.59, and a PEG ratio of 1.26 compared to the industry's 1.58, indicating valuation relative to earnings growth.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
Netflix stock price rises as CEO slams Paramount’s Warner bid, Senate hearing nears
Previous Story

Netflix stock price rises as CEO slams Paramount’s Warner bid, Senate hearing nears

Walmart stock ticks higher as PhonePe IPO share-sale details emerge — what’s next for WMT
Next Story

Walmart stock ticks higher as PhonePe IPO share-sale details emerge — what’s next for WMT

Go toTop